Early Christmas Sale - Ends Soon!
-35% Off Everything
Encompass Health Corporation (EHC)
Last Price$94.50.4%
Market Cap$9,437.1M
EHC overview
Crunching data... Almost there!
1W 0.7%
1M (8.9%)
6M 12.1%
YTD 41.5%
1Y 41.2%
3Y 90.2%
5Y 82.9%
10Y 251.6%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
EHC key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
EHC Intrinsic value
EHC Intrinsic value overview
EHC Historical intrinsic value
EHC Financials
EHC Income statement
Crunching data... Almost there!
EHC Balance sheet
Crunching data... Almost there!
EHC Cash flow statement
Crunching data... Almost there!
EHC Financial ratios
EHC Growth
Crunching data... Almost there!
EHC Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more EHC fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of Encompass Health Corporation (EHC) stock?
As of today, intrinsic value of Encompass Health Corporation is $62.5.
Is Encompass Health Corporation (EHC) stock undervalued or overvalued?
As of today, Encompass Health Corporation is overvalued by 33.9%, compared to the current market share price of $94.5.
What is Encompass Health Corporation (EHC) stock rating?
As of today, Encompass Health Corporation has a stock rating of 6 (out of 10), which is considered Good.
is Encompass Health Corporation (EHC) a good stock to buy?
As of today, Encompass Health Corporation has a Good stock rating, which is 33.9% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.